Healthcare ❯ Pharmaceuticals

Drug Approval

FDA Clinical Trials FDA Regulations Regulatory Agencies Mifepristone Generic Drugs NHS NHS Policies GLP-1 Drugs FDA Approval

White House Weighs AI Model Pre-Approval as Internal Debate Grows

National security concerns have pushed AI oversight to the top of the agenda.

Stories older than 24h

FDA Expands Tzield Use to Delay Type 1 Diabetes in Children Ages 1 to 7

Italy Opens SSN Coverage for Cytisine Quit-Smoking Pill Now Available in Pharmacies

Hims & Hers Soars as Novo Nordisk Reinstates Supply Deal for Ozempic and Wegovy

EMA Backs Single-Dose Acoziborole for Gambiense Sleeping Sickness Outside EU

NICE Recommends First Vitiligo Repigmentation Cream for NHS Use in England

FDA Approves Vanda’s Bysanti for Bipolar I Mania and Schizophrenia

Eli Lilly Builds $1.5 Billion Stockpile of Orforglipron as FDA Decision Nears

Eli Lilly Jumps on GLP‑1 Momentum as 2026 Outlook Beats and Targets Rise

Bristol Myers Gains Analyst Support as 2026 Catalysts Offset Patent-Cliff Worries

Shareholder Law Firms Expand Probes of Corcept After FDA CRL for Relacorilant

FDA Issues Second Rejection of Atara’s EBV+ PTLD Therapy Tabelecleucel

FDA Approves Vanda’s Nereus, First New Motion Sickness Treatment in Over 40 Years

Bristol Myers Enters 2026 With Eliquis Medicaid Pact, Opdivo Qvantig Rollout, and Divergent Analyst Views

FDA Clears Wegovy Weight-Loss Pill, U.S. Launch Set for January

FDA Clears First New Oral Gonorrhea Antibiotics in Over 30 Years

FDA Expands Addyi Use to Postmenopausal Women, Including Those Over 65

Texas and Florida Sue FDA to Overturn Mifepristone Approvals and Mail-Order Access

Health Canada Approves First Pill for Postpartum Depression

Arrowhead Gains FDA Approval for Redemplo as Results Surge and Shares Hit Three-Year High